What is the Impact Factor of Diabetology & Metabolic Syndrome?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Diabetology & Metabolic Syndrome is 4.90, ranking in quartile Q1 of Web of Science (SCIE).

Is Diabetology & Metabolic Syndrome indexed in Web of Science or Scopus?

Yes, Diabetology & Metabolic Syndrome is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.247 (Q1) and an H-index of 81.

Who publishes Diabetology & Metabolic Syndrome and what is the Article Processing Charge (APC)?

Diabetology & Metabolic Syndrome is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $3,428 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Diabetology & Metabolic Syndrome?

The official ISO-4 abbreviation of Diabetology & Metabolic Syndrome is "DIABETOL METAB SYNDR" with common acronym "dims". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #3,399Gold OA

Diabetology & Metabolic Syndrome

Acronym:dims

•

Abbreviation (ISO):DIABETOL METAB SYNDR

•

Identifier (ISSN):1758-5996(Print)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

4.9↑ +1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Diabetology & Metabolic Syndrome

WoS Q1

Annual Impact Factor Metric

Current (2026):4.9

Scopus SJR & RankScopus Q1

1.247

#3,399

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

81 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

149articles/year

100% Gold OA•84.9% Original Research

Aims & Scope

Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome. By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.

Topics Covered (Recognized by AI)

MedicineBiologyEndocrinologyInternal MedicinePathologyChemistryBiochemistryGeneticsMathematicsStatisticsSociologySurgeryPsychology

Primary Research Areas

Endocrinology & Metabolism

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank49/198

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank47/198

IndexSCIE

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRSCIE	49/198	Q1
ENDOCRINOLOGY & METABOLISM	JCISCIE	47/198	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.9

Articles / Year141

Total Citations18

2025

IF3.9

Articles / Year503

Total Citations1,733

2024

IF3.4

Articles / Year315

Total Citations2,560

2023

IF4.8

Articles / Year261

Total Citations3,856

2022

IF5.395

Articles / Year198

Total Citations3,502

Year	Impact Factor	Articles / Year	Total Citations
2026	4.9	141	18
2025	3.9	503	1,733
2024	3.4	315	2,560
2023	4.8	261	3,856
2022	5.395	198	3,502
2021	3.32	152	3,746
2020	2.709	108	4,782
2019	2.361	113	4,474
2018	2.413	93	3,625
2017	—	102	4,011
2016	—	84	2,841
2015	—	372	4,036

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,399Scopus Q1SCImago Profile

Scopus Coverage:2009-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.247

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.85

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,428 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,701

3-Year Documents753

Citable Documents749

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Internal MedicineQ1

Endocrinology, Diabetes and MetabolismQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Diabetology & Metabolic Syndrome (acronym: dims, abbr: DIABETOL METAB SYNDR, ISSN: 1758-5996) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by BioMed Central in Brazil since 2009. The periodical holds a Journal Impact Factor (JIF) of 4.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.247 (Q1), an H-index of 81.

The journal enforces rigorous peer evaluation with an annual output of approximately 149 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,428 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.